Menu Home

SCH Precongress

Canine and feline congenital portosystemic shunting



Date: Wednesday 20 September
Time: Full day programme of morning lectures and afternoon roundtable discussions 08.30-17.00
Venue: Hotel SB Diagonal Zero, Norte América Room 
Registration fee - onsite live precongress (incl on-demand access afterwards): SCH member - €100 | SCH non-member €160 incl. VAT
Closing date for registration is Monday 14th of August

Registration fee - online live & on-demand precongress: SCH member - € 30 | SCH non-member € 90 incl. VAT
Closing date for registration is Monday 18th of September
In case of questions concerning the live-stream and on-demand connections and link, please contact the society via comparativehepatology@gmail.com

Registration: Online pre-registration via ECVIM-CA Congress registration or on-demand ECVIM-CA Congress registration 

Programme

Lectures (morning)

08.30-09.00 Coffee starter

09.00-09.10 Welcome, sponsor thanking (Royal Canin) and housekeeping
09.10-09.50 cPSS genetics and genetic predictors of outcome | Frank van Steenbeek (Utrecht, Netherlands)
09.50-10.30 cPSS morphology and embryology, including their clinical significance | Mickey Tivers (Wakefield, England)

10.30-11.00 Coffee break

11.00-11.40 Dissecting cPSS complications: HE (including pathogenesis); gastrointestinal haemorrhage | Adam Gow (Edinburgh, Scotland)
11.40-12.20 Biomarkers for cPSS diagnosis and surgical attenuation success assessment: current evidence and clinical significance | Nausikaa Devriendt (Ghent, Belgium)

12.20-13.30 Lunch

Roundtable discussions and Q&A from audience (afternoon)

Panel
Frank van Steenbeek (Utrecht, Netherlands), Mickey Tivers (Wakefield, England), Adam Gow (Edinburgh, Scotland), Nausikaa Devriendt (Ghent, Belgium), Chick Weisse (New York, USA)

13.30
Pros and cons

  • Medical vs surgical management: how to arrive at an evidence-based decision on whether to treat a dog or cat with a cPSS medically or surgically?
  • Interventional vs non-interventional: which methods achieve best outcome for cIHPSS and cEHPSS, respectively?

cPSS attenuation

  • What do you consider before undergoing attenuation?
  • Assessing vs not assessing closure post-procedurally
  • How and when do you measure post-operative success after surgical attenuation? Which biomarkers or imaging techniques?

15.00-15.30 Coffee break

15.30
How to deal with peri/postoperative complications

  • Decide on the value of preoperative use of antiepileptics in management of post-ligation neurological syndrome
  • How to deal with acute portal hypertension cases after coiling

Controversies in the medical management and monitoring response to treatment

  • Discuss the nutritional management of young growing dogs with hepatic supportive diets
  • Decide on the use of antibiotics on the long-term of medical therapy
  • Discuss the use of proton pump inhibitors before and after cIHPSS attenuation
  • When to stop medical therapy after surgery?

16.40-17.00 Final questions, thank you and goodbye

 

For more information on renewing your membership or if you’re interested in joining the SCH, please go to https://comparativehepatology.org/
Please contact us by email (comparativehepatology@gmail.com) if you experience any PayPal account issues when paying for membership

 

Programme